ASH 2019: Trials of AML Treatment Should Liberalize Inclusion Criteria

Read it now on PracticeUpdate.com

Source: PracticeUpdate

Categories: Hem/Oncs

Tags: ASH19

Tweets with this article

Oncology

#ASH19: Trials of Acute Myeloid Leukemia Treatment Should Liberalize Inclusion Criteria to Allow for More Comorbidities https://t.co/bRCKU0qX2D @ASH_hematology

Management Strategies for Hypogammaglobulinemia Secondary to B-Cell–Depleting Therapies

Read it now on PracticeUpdate.com

PracticeUpdate July 18, 2023

Major Adverse Cardiovascular Events in Patients Treated With Oral JAK Inhibitors for Atopic Dermatitis

Read it now on PracticeUpdate.com

PracticeUpdate July 18, 2023

Safety and Effectiveness of Metformin Plus Lifestyle Intervention vs Lifestyle Intervention Alone in Preventing Diabetes Progression in a Chinese Population With Impaired Glucose Regulation

Read it now on PracticeUpdate.com

PracticeUpdate July 18, 2023

Ribociclib and Endocrine Therapy as Adjuvant Treatment in HR+/HER2− Early Breast Cancer

Interview with Lee S. Schwartzberg MD, FACP

PracticeUpdate July 7, 2023

9th Congress of the European Academy of Neurology (EAN)

Read it now on PracticeUpdate.com

PracticeUpdate July 7, 2023

Nivolumab Plus Brentuximab Vedotin for Low-Risk Relapsed Classic Hodgkin Lymphoma

Interview with David Henry MD

David Henry July 7, 2023

Circulating Tumor DNA Following Neoadjuvant Chemotherapy and Surgery in ER-Positive and HER2-Negative Breast Cancer

Interview with David Henry MD

David Henry July 6, 2023

Neoadjuvant Chemoradiation for Treatment of LARC

Interview with David Henry MD

David Henry July 5, 2023

Dara-CVRd as Induction and Extended Consolidation Improves Outcomes in Patients With Ultra–High-Risk Multiple Myeloma

Written by Rafael Fonseca MD

Rafael Fonseca MD 🇺🇸🏜🇲🇽 July 1, 2023

Enhancing Lung Cancer Screening

Interview with Atulya A. Khosla MD

David Henry June 28, 2023

Related Articles